CN113567421B - Quantitative detection method for multiple markers - Google Patents
Quantitative detection method for multiple markers Download PDFInfo
- Publication number
- CN113567421B CN113567421B CN202110818188.0A CN202110818188A CN113567421B CN 113567421 B CN113567421 B CN 113567421B CN 202110818188 A CN202110818188 A CN 202110818188A CN 113567421 B CN113567421 B CN 113567421B
- Authority
- CN
- China
- Prior art keywords
- channel
- detection
- reaction
- liquid
- mixing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 144
- 239000007788 liquid Substances 0.000 claims abstract description 179
- 238000006243 chemical reaction Methods 0.000 claims abstract description 104
- 238000002156 mixing Methods 0.000 claims abstract description 103
- 239000002699 waste material Substances 0.000 claims abstract description 32
- 238000005406 washing Methods 0.000 claims abstract description 24
- 239000003550 marker Substances 0.000 claims abstract description 21
- 239000000758 substrate Substances 0.000 claims abstract description 20
- 239000000427 antigen Substances 0.000 claims abstract description 10
- 102000036639 antigens Human genes 0.000 claims abstract description 10
- 108091007433 antigens Proteins 0.000 claims abstract description 10
- 239000012535 impurity Substances 0.000 claims abstract description 9
- 108090000790 Enzymes Proteins 0.000 claims abstract description 4
- 102000004190 Enzymes Human genes 0.000 claims abstract description 4
- 239000000243 solution Substances 0.000 claims description 32
- 238000003860 storage Methods 0.000 claims description 20
- 239000003153 chemical reaction reagent Substances 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 15
- 239000011259 mixed solution Substances 0.000 claims description 13
- 238000002347 injection Methods 0.000 claims description 5
- 239000007924 injection Substances 0.000 claims description 5
- 238000011534 incubation Methods 0.000 claims description 4
- 238000013459 approach Methods 0.000 claims description 3
- 238000003825 pressing Methods 0.000 claims description 3
- 230000003068 static effect Effects 0.000 claims description 3
- 238000005070 sampling Methods 0.000 abstract description 5
- 238000004020 luminiscence type Methods 0.000 abstract description 4
- 239000000126 substance Substances 0.000 abstract description 2
- 101100537532 Rattus norvegicus Tnni3 gene Proteins 0.000 description 21
- -1 CK-MB Proteins 0.000 description 12
- 239000012530 fluid Substances 0.000 description 10
- 230000002107 myocardial effect Effects 0.000 description 10
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 9
- 238000010586 diagram Methods 0.000 description 6
- 238000012986 modification Methods 0.000 description 6
- 230000004048 modification Effects 0.000 description 6
- 238000007781 pre-processing Methods 0.000 description 5
- 230000001360 synchronised effect Effects 0.000 description 5
- 230000008901 benefit Effects 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 238000002965 ELISA Methods 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 description 3
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000012123 point-of-care testing Methods 0.000 description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000008105 immune reaction Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 2
- 238000004987 plasma desorption mass spectroscopy Methods 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 239000011534 wash buffer Substances 0.000 description 2
- 208000030090 Acute Disease Diseases 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 102000004420 Creatine Kinase Human genes 0.000 description 1
- 108010042126 Creatine kinase Proteins 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- 108010044467 Isoenzymes Proteins 0.000 description 1
- 102000036675 Myoglobin Human genes 0.000 description 1
- 108010062374 Myoglobin Proteins 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 102100036859 Troponin I, cardiac muscle Human genes 0.000 description 1
- 101710128251 Troponin I, cardiac muscle Proteins 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 206010000891 acute myocardial infarction Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 238000002038 chemiluminescence detection Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/76—Chemiluminescence; Bioluminescence
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5302—Apparatus specially adapted for immunological test procedures
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Plasma & Fusion (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Automatic Analysis And Handling Materials Therefor (AREA)
Abstract
本发明公开了一种多标志物定量检测方法,包括以下步骤,同时抽取检测样本和检测抗体进入检测芯片的混合通道,检测样本和检测抗体在混合通道内循环抽吸充分混合,混合结束,混合溶液进入反应通道;静止孵育,与反应通道位置对应的反应层上包被的捕获抗体特异性地吸附抗原,形成捕获抗体‑抗原‑检测抗体这种双抗体夹心结构;将反应过后的溶液抽入废液池;洗涤液将混合通道和反应通道未参与反应的杂质以及未结合的检测抗体冲进废液池;化学发光底物经过混合通道进入反应通道,与检测抗体上标记的酶反应产生化学发光;本发明能实现多个溶液同步进样,检测效率高。
The invention discloses a multi-marker quantitative detection method, which includes the following steps: simultaneously extracting detection samples and detection antibodies into the mixing channel of the detection chip, and circulating the detection samples and detection antibodies in the mixing channel to fully mix. After the mixing is completed, the mixing The solution enters the reaction channel; it is incubated statically, and the capture antibody coated on the reaction layer corresponding to the position of the reaction channel specifically adsorbs the antigen, forming a double-antibody sandwich structure of capture antibody-antigen-detection antibody; the reacted solution is pumped into Waste liquid pool; the washing liquid flushes the impurities that did not participate in the reaction of the mixing channel and reaction channel and the unbound detection antibody into the waste liquid pool; the chemiluminescent substrate enters the reaction channel through the mixing channel, and reacts with the enzyme labeled on the detection antibody to produce chemical Luminescence; the invention can realize simultaneous sampling of multiple solutions and has high detection efficiency.
Description
技术领域Technical field
本发明涉及标志物检测技术领域,特别是一种多标志物定量检测方法。The invention relates to the technical field of marker detection, in particular to a multi-marker quantitative detection method.
背景技术Background technique
即时检验是指在采样现场进行的、利用便携式分析仪器及配套试剂快速得到检测结果的一种检测方式。与传统实验室设备相比,POCT设备具有设备便携、检测快速、对人员操作技术要求低以及便于维护等多方面优势。尤其对急性病而言,利用POCT技术深入救护车、家庭、社区进行自我早期筛查是保障健康的有力手段。Point-of-care testing refers to a testing method that uses portable analytical instruments and supporting reagents to quickly obtain test results at the sampling site. Compared with traditional laboratory equipment, POCT equipment has many advantages such as portability, fast detection, low technical requirements for personnel operation, and easy maintenance. Especially for acute diseases, using POCT technology to conduct early self-screening in ambulances, homes, and communities is a powerful means to protect health.
酶联免疫吸附测定法(ELISA),是一种基于抗原抗体特异性结合这一免疫反应的方法。基于ELISA发展出适用于大分子蛋白的双抗体夹心法、适用于小分子蛋白的竞争法等多种方法。现有技术中,在检测时,需要分步加样,多次洗涤,存在检测时间长、试剂消耗大的问题,对操作人员有很高的技术要求。Enzyme-linked immunosorbent assay (ELISA) is an immune reaction method based on the specific binding of antigens and antibodies. Based on ELISA, various methods such as the double-antibody sandwich method suitable for macromolecular proteins and the competition method suitable for small molecule proteins have been developed. In the existing technology, during detection, samples need to be added step by step and washed multiple times. There are problems such as long detection time and high reagent consumption, which places high technical requirements on operators.
发明内容Contents of the invention
本部分的目的在于概述本发明的实施例的一些方面以及简要介绍一些较佳实施例。在本部分以及本申请的说明书摘要和发明名称中可能会做些简化或省略以避免使本部分、说明书摘要和发明名称的目的模糊,而这种简化或省略不能用于限制本发明的范围。The purpose of this section is to outline some aspects of embodiments of the invention and to briefly introduce some preferred embodiments. Some simplifications or omissions may be made in this section, the abstract and the title of the invention to avoid obscuring the purpose of this section, the abstract and the title of the invention, and such simplifications or omissions cannot be used to limit the scope of the invention.
鉴于上述和/或现有的标志物检测中存在的问题,提出了本发明。In view of the above and/or problems existing in existing marker detection, the present invention is proposed.
因此,本发明的目的是提供一种多标志物定量检测方法,其实现同步进样,检测时间短,试剂消耗少,检测效率高。Therefore, the object of the present invention is to provide a method for quantitative detection of multiple markers, which achieves simultaneous sample injection, short detection time, low reagent consumption, and high detection efficiency.
为解决上述技术问题,本发明提供如下技术方案:一种多标志物定量检测方法,其包括以下步骤,In order to solve the above technical problems, the present invention provides the following technical solution: a multi-marker quantitative detection method, which includes the following steps:
同时抽取检测样本和检测抗体进入检测芯片的混合通道,检测样本和检测抗体在混合通道内循环抽吸充分混合,混合结束,混合溶液进入反应通道;At the same time, the detection sample and detection antibody are extracted into the mixing channel of the detection chip. The detection sample and detection antibody are circulated and pumped in the mixing channel to fully mix. After the mixing is completed, the mixed solution enters the reaction channel;
静止孵育,与反应通道位置对应的反应层上包被的捕获抗体特异性地吸附抗原,形成捕获抗体-抗原-检测抗体这种双抗体夹心结构;After static incubation, the capture antibody coated on the reaction layer corresponding to the position of the reaction channel specifically adsorbs the antigen, forming a double-antibody sandwich structure of capture antibody-antigen-detection antibody;
将反应过后的溶液抽入废液池;Pump the reacted solution into the waste pool;
洗涤液将混合通道和反应通道未参与反应的杂质以及未结合的检测抗体冲进废液池;The washing liquid flushes the impurities that did not participate in the reaction in the mixing channel and reaction channel and the unbound detection antibodies into the waste liquid pool;
化学发光底物经过混合通道进入反应通道,与检测抗体反应产生化学发光。The chemiluminescent substrate enters the reaction channel through the mixing channel and reacts with the detection antibody to produce chemiluminescence.
作为本发明所述多标志物定量检测方法的一种优选方案,其中:所述检测芯片包括芯片组件,所述芯片组件包括第一芯片本体和在第一芯片本体下侧的第二芯片本体,所述第一芯片本体朝下的一端设有若干储液池、一个混合通道和一个反应通道,反应通道远离储液池一端的第一芯片本体上设有第一负压接口,所述第一芯片本体上开有若干与储液池一一对应且连通的进样通气孔,储液池能与混合通道的一端连通,混合通道的另一端与反应通道的一端相接,所述反应通道的另一端与废液池相接,废液池与第一负压接口连通,第一芯片本体和第二芯片本体之间设有与反应通道所在位置对应的反应层。As a preferred solution of the multi-marker quantitative detection method of the present invention, the detection chip includes a chip assembly, and the chip assembly includes a first chip body and a second chip body on the lower side of the first chip body, The downward end of the first chip body is provided with several liquid reservoirs, a mixing channel and a reaction channel. The first chip body at one end of the reaction channel away from the liquid reservoir is provided with a first negative pressure interface. There are a number of sampling vents on the chip body that correspond to and are connected to the liquid storage tank. The liquid storage tank can be connected to one end of the mixing channel, and the other end of the mixing channel is connected to one end of the reaction channel. The reaction channel has The other end is connected to the waste liquid pool, the waste liquid pool is connected to the first negative pressure interface, and a reaction layer corresponding to the position of the reaction channel is provided between the first chip body and the second chip body.
作为本发明所述多标志物定量检测方法的一种优选方案,其中:所述第一芯片本体上开有使储液池能与混合通道一端连通的上阀孔。As a preferred solution of the multi-marker quantitative detection method of the present invention, the first chip body is provided with an upper valve hole that allows the liquid reservoir to communicate with one end of the mixing channel.
作为本发明所述多标志物定量检测方法的一种优选方案,其中:所述检测芯片还包括控制组件,所述控制组件包括机械阀、连接在一起的第一支撑支架和第二支撑支架,芯片组件支撑在第一支撑支架和第二支撑支架之间,第二芯片本体上开有与上阀孔同轴心的下阀孔,第一支撑支架和第二支撑支架上分别开有第一导向孔和第二导向孔,所述机械阀穿过第一导向孔并压入上阀孔后,机械阀的下端能再依次穿过下阀孔和第二导向孔。As a preferred solution of the multi-marker quantitative detection method of the present invention, the detection chip further includes a control component, and the control component includes a mechanical valve, a first support bracket and a second support bracket connected together, The chip assembly is supported between the first support bracket and the second support bracket. The second chip body is provided with a lower valve hole that is coaxial with the upper valve hole. The first support bracket and the second support bracket are respectively provided with first guide hole and second guide hole. After the mechanical valve passes through the first guide hole and is pressed into the upper valve hole, the lower end of the mechanical valve can pass through the lower valve hole and the second guide hole in sequence.
作为本发明所述多标志物定量检测方法的一种优选方案,其中:所述第一芯片本体上还开有第二负压接口,所述第二负压接口与混合通道的一端相接。As a preferred solution of the multi-marker quantitative detection method of the present invention, the first chip body is also provided with a second negative pressure interface, and the second negative pressure interface is connected to one end of the mixing channel.
作为本发明所述多标志物定量检测方法的一种优选方案,其中:所述机械阀上设有若干在高度方向上间隔设置的出液通道,所述储液池能经对应的出液通道与混合通道的一端连通,当储液池经出液通道与混合通道刚好连通时,储液池覆盖出液通道的一端,混合通道的一端覆盖出液通道的另一端。As a preferred solution of the multi-marker quantitative detection method of the present invention, the mechanical valve is provided with a number of liquid outlet channels spaced in the height direction, and the liquid storage tank can pass through the corresponding liquid outlet channels. It is connected to one end of the mixing channel. When the liquid reservoir is just connected to the mixing channel through the liquid outlet channel, the liquid reservoir covers one end of the liquid outlet channel, and one end of the mixing channel covers the other end of the liquid outlet channel.
作为本发明所述多标志物定量检测方法的一种优选方案,其中:所述机械阀上设有导向凸起,所述导向凸起与混合通道一端位置对齐时,最下面的出液通道的进液端能与多个储液池对应,最下面的出液通道具有至少两个进液端,当最下面的出液通道下端与第一芯片本体下侧齐平时,至少有两个储液池分别覆盖不同的进液端。As a preferred solution of the multi-marker quantitative detection method of the present invention, the mechanical valve is provided with a guide protrusion. When the guide protrusion is aligned with one end of the mixing channel, the bottom liquid outlet channel is The liquid inlet end can correspond to multiple liquid reservoirs. The bottom liquid outlet channel has at least two liquid inlet ends. When the lower end of the bottom liquid outlet channel is flush with the lower side of the first chip body, there are at least two liquid storage tanks. The pools cover different liquid inlet ends respectively.
作为本发明所述多标志物定量检测方法的一种优选方案,其中:检测前,将导向凸起与混合通道一端的位置对齐,下压机械阀使其压入上阀孔,当最下面的出液通道被按压至第一芯片本体下侧所在位置时,储液池与出液通道的两个进液端对应,停止下压机械阀,将检测样本、检测抗体、洗涤液和化学发光底物分别注入不同的储液池内,在第一负压接口和第二负压接口处分别连接第一负压泵和第二负压泵。As a preferred solution of the multi-marker quantitative detection method of the present invention, before detection, align the guide protrusion with the position of one end of the mixing channel, press down the mechanical valve to press it into the upper valve hole, when the bottom When the liquid outlet channel is pressed to the lower side of the first chip body, the liquid reservoir corresponds to the two liquid inlet ends of the liquid outlet channel, stop pressing the mechanical valve, and transfer the detection sample, detection antibody, washing solution and chemiluminescent substrate. The materials are respectively injected into different liquid reservoirs, and the first negative pressure pump and the second negative pressure pump are respectively connected to the first negative pressure interface and the second negative pressure interface.
作为本发明所述多标志物定量检测方法的一种优选方案,其中:混合检测样本和检测抗体时,第一负压泵先动作,将检测样本和检测抗体抽进混合通道内,当抽入的试剂靠近混合通道另一端时,第一负压泵停止动作,第二负压泵工作,将流向混合通道另一端的混合溶液朝着混合通道一端所在方向流动,完成一次循环混合,反复上述步骤,当循环混合次数达到设定的次数阈值时,第二负压泵停止动作,第一负压泵将混合好的溶液吸至反应通道内反应。As a preferred solution of the multi-marker quantitative detection method of the present invention, when mixing the detection sample and the detection antibody, the first negative pressure pump operates first to pump the detection sample and the detection antibody into the mixing channel. When the reagent approaches the other end of the mixing channel, the first negative pressure pump stops and the second negative pressure pump works to flow the mixed solution flowing to the other end of the mixing channel in the direction of one end of the mixing channel to complete a cycle of mixing and repeat the above steps. , when the number of circulation mixing reaches the set threshold, the second negative pressure pump stops operating, and the first negative pressure pump sucks the mixed solution into the reaction channel for reaction.
作为本发明所述多标志物定量检测方法的一种优选方案,其中:反应结束后,向下按压机械阀,使中间的出液通道与注入有洗涤液的储液池对应,第一负压泵动作,将洗涤液依次经出液通道、混合通道和反应通道后冲进废液池,洗去反应层上未参与反应的杂质及未结合的检测抗体;继续向下按压机械阀,使最上面的出液通道与注入有化学发光底物的储液池对应,第一负压泵动作,将化学发光底物抽入反应通道内,与检测抗体上标记的酶反应,产生化学发光;反应通道上横向的直线微通道与反应层上竖向包被的抗体条带构成发光点阵,测量得到各点的化学发光值。As a preferred solution of the multi-marker quantitative detection method of the present invention, after the reaction is completed, the mechanical valve is pressed downward to make the middle liquid outlet channel correspond to the liquid storage tank in which the washing liquid is injected, and the first negative pressure The pump operates, and the washing liquid flows through the outlet channel, mixing channel and reaction channel in sequence and then rushes into the waste liquid pool to wash away the impurities and unbound detection antibodies on the reaction layer that do not participate in the reaction; continue to press the mechanical valve downward to allow the final The upper outlet channel corresponds to the liquid reservoir in which the chemiluminescent substrate is injected. The first negative pressure pump operates to pump the chemiluminescent substrate into the reaction channel, where it reacts with the enzyme labeled on the detection antibody to produce chemiluminescence; reaction The horizontal linear microchannels on the channel and the vertically coated antibody strips on the reaction layer form a luminescent lattice, and the chemiluminescence value of each point is measured.
本发明的有益效果:使用本发明能实现多种标志物的联合同步检测,且能实现同步进样,不同的试剂混合时,通过多次循环混合,使试剂充分混合均匀,避免在混合通道中堵塞,提高检测精度,无需分多次洗涤,试剂损耗少,检测成本低。Beneficial effects of the present invention: the use of the present invention can realize joint and synchronous detection of multiple markers, and can realize synchronous sampling. When different reagents are mixed, the reagents can be fully mixed evenly through multiple circulation mixing to avoid mixing in the mixing channel. Blockage, improve detection accuracy, no need for multiple washings, less reagent loss, and low detection cost.
附图说明Description of the drawings
为了更清楚地说明本发明实施例的技术方案,下面将对实施例描述中所需要使用的附图作简单地介绍,显而易见地,下面描述中的附图仅仅是本发明的一些实施例,对于本领域普通技术人员来讲,在不付出创造性劳动性的前提下,还可以根据这些附图获得其它的附图。其中:In order to explain the technical solutions of the embodiments of the present invention more clearly, the drawings needed to be used in the description of the embodiments will be briefly introduced below. Obviously, the drawings in the following description are only some embodiments of the present invention. Those of ordinary skill in the art can also obtain other drawings based on these drawings without exerting any creative effort. in:
图1为本发明的立体结构图。Figure 1 is a three-dimensional structural view of the present invention.
图2为本发明的爆炸结构图。Figure 2 is an exploded structural diagram of the present invention.
图3为本发明中第一芯片本体的立体结构图。Figure 3 is a three-dimensional structural view of the first chip body in the present invention.
图4为本发明中溶液混合后在混合通道和反应通道内的流速。Figure 4 shows the flow rate in the mixing channel and the reaction channel after the solution is mixed in the present invention.
图5为本发明中溶液混合过程中在混合通道和反应通道内的浓度变化图。Figure 5 is a diagram showing concentration changes in the mixing channel and the reaction channel during the solution mixing process in the present invention.
图6为本发明中溶液混合结束后在混合通道和反应通道内的浓度变化图。Figure 6 is a graph showing concentration changes in the mixing channel and the reaction channel after the solution is mixed in the present invention.
图7为本发明的检测原理说明图。Figure 7 is an explanatory diagram of the detection principle of the present invention.
图8为本发明中反应层捕获抗体包被示意图。Figure 8 is a schematic diagram of the reaction layer capturing antibody coating in the present invention.
图9为本发明检测cTnI、CK-MB、Myo三种心肌标志物的检测范围曲线图。Figure 9 is a graph showing the detection range of three myocardial markers, cTnI, CK-MB, and Myo, according to the present invention.
图10为本发明中检测cTnI、CK-MB、Myo三种心肌标志物的线性曲线图。Figure 10 is a linear graph for detecting three myocardial markers, cTnI, CK-MB, and Myo, in the present invention.
图11为本发明进行cTnI、CK-MB、Myo三种心肌标志物单独检测的发光点阵图。Figure 11 is a luminescence dot matrix diagram of the present invention for separate detection of three myocardial markers: cTnI, CK-MB, and Myo.
图12为本发明进行cTnI、CK-MB、Myo三种心肌标志物联合检测的发光点阵图。Figure 12 is a luminescence dot matrix diagram of the present invention for joint detection of three myocardial markers, cTnI, CK-MB, and Myo.
图中,100控制组件,101第二支撑支架,101a第二连接孔,101b第二导向孔,102第一支撑支架,102a第一连接孔,102b第一导向孔,103机械阀,103a出液通道,103b导向凸起,104连接销,200芯片组件,201第一芯片本体,201a进样通气孔,201b上阀孔,201c第一负压接口,201d第二负压接口,201e储液池,201e-1第一储液池,201e-2第二储液池,201e-3第三储液池,201e-4第四储液池,201f混合通道,201g反应通道,201g-1连接微通道,201g-2直线微通道,201h废液池,202第二芯片本体,202a下阀孔,203反应层。In the figure, 100 control component, 101 second support bracket, 101a second connection hole, 101b second guide hole, 102 first support bracket, 102a first connection hole, 102b first guide hole, 103 mechanical valve, 103a liquid outlet Channel, 103b guide protrusion, 104 connecting pin, 200 chip assembly, 201 first chip body, 201a injection vent, 201b upper valve hole, 201c first negative pressure interface, 201d second negative pressure interface, 201e liquid reservoir , 201e-1 first liquid reservoir, 201e-2 second liquid reservoir, 201e-3 third liquid reservoir, 201e-4 fourth liquid reservoir, 201f mixing channel, 201g reaction channel, 201g-1 connection micro Channel, 201g-2 linear microchannel, 201h waste liquid pool, 202 second chip body, 202a lower valve hole, 203 reaction layer.
实施方式Implementation
在阐述本发明的技术方案之前,定义本文使用的术语如下:Before elaborating the technical solutions of the present invention, the terms used in this article are defined as follows:
术语“PC”是指:聚碳酸酯;The term "PC" refers to: polycarbonate;
术语“PDMS”是指:聚二甲基硅氧烷;The term "PDMS" refers to: polydimethylsiloxane;
术语“AMI”是指:急性心肌梗死;The term "AMI" means: acute myocardial infarction;
术语“cTnI”是指:心肌肌钙蛋白I;The term "cTnI" refers to: cardiac troponin I;
术语“Myo”是指:肌红蛋白;The term "Myo" refers to: myoglobin;
术语“CK-MB”是指:肌酸激酶同工酶;The term "CK-MB" refers to: creatine kinase isoenzyme;
术语“HRP”是指:辣根过氧化物酶;The term "HRP" refers to: horseradish peroxidase;
术语“BSA”是指:牛血清白蛋白;The term "BSA" refers to: bovine serum albumin;
术语“PBST”是指:含有0.05% 吐温20的磷酸盐缓冲液。The term "PBST" refers to: phosphate buffered saline containing 0.05% Tween 20.
为使本发明的上述目的、特征和优点能够更加明显易懂,下面结合说明书附图对本发明的具体实施方式做详细的说明。In order to make the above objects, features and advantages of the present invention more obvious and understandable, the specific implementation modes of the present invention will be described in detail below with reference to the accompanying drawings.
在下面的描述中阐述了很多具体细节以便于充分理解本发明,但是本发明还可以采用其他不同于在此描述的其它方式来实施,本领域技术人员可以在不违背本发明内涵的情况下做类似推广,因此本发明不受下面公开的具体实施例的限制。Many specific details are set forth in the following description to fully understand the present invention. However, the present invention can also be implemented in other ways different from those described here. Those skilled in the art can do so without departing from the connotation of the present invention. Similar generalizations are made, and therefore the present invention is not limited to the specific embodiments disclosed below.
其次,此处所称的“一个实施例”或“实施例”是指可包含于本发明至少一个实现方式中的特定特征、结构或特性。在本说明书中不同地方出现的“在一个实施例中”并非均指同一个实施例,也不是单独的或选择性的与其他实施例互相排斥的实施例。Second, reference herein to "one embodiment" or "an embodiment" refers to a specific feature, structure, or characteristic that may be included in at least one implementation of the present invention. "In one embodiment" appearing in different places in this specification does not all refer to the same embodiment, nor is it a separate or selective embodiment that is mutually exclusive with other embodiments.
实施例Example
参照图8,为本发明的第一个实施例,该实施例用于说明捕获抗体的包被与检测芯片的预处理,包括以下步骤,Refer to Figure 8, which is a first embodiment of the present invention. This embodiment is used to illustrate the coating of capture antibodies and the preprocessing of the detection chip, including the following steps:
在反应层203上竖向放置一块具有多直线通道的PDMS微流控芯片,通道宽500 μm,深300 μm ,间距3 mm平行排布,将捕获抗体溶液分别注入通道中,根据检测标志物数量的不同选择不同的通道注入,1小时后用PBST洗涤液清洗反应层203三次,去除未包被成功的捕获抗体,捕获抗体即包被在反应层203上。Place a PDMS microfluidic chip with multiple linear channels vertically on the reaction layer 203. The channels are 500 μm wide, 300 μm deep, and arranged in parallel with a spacing of 3 mm. Inject the capture antibody solutions into the channels respectively, and according to the number of detection markers Different channels are selected for injection, and after 1 hour, the reaction layer 203 is washed three times with PBST washing solution to remove the capture antibodies that have not been successfully coated, and the capture antibodies are coated on the reaction layer 203.
在检测芯片组装完成后,向第一个储液池201e内加入50μl 5% BSA溶液,按压机械阀103使最下面的出液通道103a与第一个储液池201e所在高度对应,将BSA溶液抽入出液通道103a中,直至充满整个通道,静止孵育15分钟,以封闭出液通道103a及反应层203上未封闭的空余位点,避免非特异性吸附,最后将BSA溶液全部抽入检测芯片的废液池201h中,将机械阀103恢复原位,至此,芯片的预处理完成。After the detection chip is assembled, add 50 μl of 5% BSA solution into the first liquid reservoir 201e, press the mechanical valve 103 to make the bottom liquid outlet channel 103a correspond to the height of the first liquid reservoir 201e, and add the BSA solution Pump into the liquid outlet channel 103a until the entire channel is filled, and incubate statically for 15 minutes to seal the unblocked empty sites on the liquid outlet channel 103a and the reaction layer 203 to avoid non-specific adsorption. Finally, pump all the BSA solution into the detection chip. In the waste liquid pool 201h, the mechanical valve 103 is restored to its original position. At this point, the preprocessing of the chip is completed.
实施例Example
为本发明的第二个实施例,该实施例提供了一种多标志物定量检测方法,其检测效率高,耗材少,降低检测成本。The second embodiment of the present invention provides a multi-marker quantitative detection method with high detection efficiency, low consumables, and reduced detection costs.
一种多标志物定量检测方法,包括以下步骤,A multi-marker quantitative detection method, including the following steps:
同时抽取检测样本和检测抗体进入检测芯片的混合通道201f,检测样本和检测抗体在混合通道201f内循环抽吸充分混合,混合结束,混合溶液进入反应通道201g;At the same time, the detection sample and the detection antibody are extracted into the mixing channel 201f of the detection chip. The detection sample and the detection antibody are circulated and pumped in the mixing channel 201f to mix thoroughly. After the mixing is completed, the mixed solution enters the reaction channel 201g;
静止孵育,与反应通道201g位置对应的反应层203上包被的捕获抗体特异性地吸附抗原,抗原与检测抗体特异性结合,形成捕获抗体-抗原-检测抗体这种双抗体夹心结构;After static incubation, the capture antibody coated on the reaction layer 203 corresponding to the position of the reaction channel 201g specifically adsorbs the antigen, and the antigen specifically combines with the detection antibody to form a double-antibody sandwich structure of capture antibody-antigen-detection antibody;
将反应过后的溶液抽入废液池201h;Pump the reacted solution into the waste liquid pool for 201 hours;
洗涤液将混合通道201f和反应通道201g未参与反应的杂质以及未结合的检测抗体冲进废液池201h;The washing liquid flushes the impurities that do not participate in the reaction and the unbound detection antibodies in the mixing channel 201f and the reaction channel 201g into the waste liquid pool 201h;
化学发光底物经过混合通道201f进入反应通道201g,与检测抗体反应产生化学发光;The chemiluminescent substrate enters the reaction channel 201g through the mixing channel 201f, and reacts with the detection antibody to produce chemiluminescence;
将芯片组件200放入化学发光检测仪器中曝光,反应通道201g横向的直线微通道201g-2与反应层203上竖向包被的抗体条带构成发光点阵,测量得到各点的化学发光值,将他们的平均灰度值减去背景值即可用于样品浓度的计算。Put the chip assembly 200 into a chemiluminescence detection instrument and expose it. The horizontal linear microchannel 201g-2 of the reaction channel 201g and the vertically coated antibody strips on the reaction layer 203 form a luminescent lattice, and the chemiluminescence value of each point is measured. , their average gray value minus the background value can be used to calculate the sample concentration.
其中,检测样本为稀释后的血清样本或抗原的标准溶液,检测抗体为与HRP偶联的检测抗体,洗涤液为PBST洗涤液,化学发光底物为Luminol-H2O2化学发光底物。Among them, the detection sample is a diluted serum sample or a standard solution of the antigen, the detection antibody is a detection antibody coupled to HRP, the washing liquid is PBST washing liquid, and the chemiluminescent substrate is Luminol-H 2 O 2 chemiluminescent substrate.
实施例Example
参照图1~图3,为本发明的第三个实施例,与第一个实施例的不同之处在于, 对检测芯片具体结构进行说明,以及使用检测芯片用于实施例2时,对实施例2相关步骤的补充说明。Referring to Figures 1 to 3, a third embodiment of the present invention is shown. The difference from the first embodiment is that the specific structure of the detection chip is described, and when the detection chip is used in Embodiment 2, the implementation Supplementary instructions for steps related to Example 2.
检测芯片包括芯片组件200,芯片组件200包括第一芯片本体201和在第一芯片本体201下侧的第二芯片本体202,第一芯片本体201朝下的一端设有若干储液池201e、一个混合通道201f和一个反应通道201g,反应通道201g包括若干段相互平行的直线微通道201g-2,相邻两个直线微通道201g-2之间经弧形的连接微通道201g-1连接在一起,首端的直线微通道201g-2经连接微通道201g-1与混合通道201f的另一端相接,反应通道201g远离储液池201e一端的第一芯片本体201上设有第一负压接口201c,第一负压接口201c的直径为1 mm的通孔,贯穿第一芯片本体201,第一芯片本体201上开有若干与储液池201e一一对应且连通的进样通气孔201a,储液池201e由长4 mm,宽3 mm的矩形以及宽度方向上的两个直径为3mm的半圆构成,储液池201e深度为3 mm,总容积约为60 μL,储液池201e能与混合通道201f的一端连通,第一芯片本体201上开有使储液池201e能与混合通道201f一端连通的上阀孔201b,混合通道201f的另一端与反应通道201g的一端相接,混合通道201f一端从外往里逐渐环绕然后再从里往外反向环绕出去到混合通道201f的另一端,从外往里环绕时半径逐渐减小,具体的,混合通道201f的前半部分由以混合通道201f的中心由半径分别为7 mm、5mm、3 mm和1 mm的半圆首尾相连构成,从最里端向外反向绕出时半径逐渐变大,混合通道201f的后半部分由以混合通道201f的中心由半径分别为1 mm、3 mm、5 mm和7 mm的半圆首尾相连构成,反应通道201g的另一端与废液池201h相接,反应通道201g的宽为400 μm,深400 μm,相邻两个直线微通道201g-2之间的间距为3 mm,直线微通道201g-2的长为10 mm,连接微通道201g-1为直径为3 mm的半圆,废液池201h与第一负压接口201c连通,第一芯片本体201和第二芯片本体202之间设有与反应通道201g所在位置对应的反应层203,反应层203是长10 mm,宽10 mm,厚0.1 mm的硅胶板,废液池201h由长为20 mm、宽5 mm的矩形以及宽度方向上的两个直径为5 mm的半圆构成,废液池201h深度为4 mm,总容积约为400 μL,废液池201h用于容纳检测过程中的废液,避免废液外溢污染环境以及仪器,其容积可以承载储液池201e中的所有试剂。The detection chip includes a chip assembly 200. The chip assembly 200 includes a first chip body 201 and a second chip body 202 on the lower side of the first chip body 201. The downward end of the first chip body 201 is provided with several liquid reservoirs 201e, a Mixing channel 201f and a reaction channel 201g. The reaction channel 201g includes several linear microchannels 201g-2 that are parallel to each other. Two adjacent linear microchannels 201g-2 are connected together by an arc-shaped connecting microchannel 201g-1. , the linear microchannel 201g-2 at the first end is connected to the other end of the mixing channel 201f through the connecting microchannel 201g-1, and the first negative pressure interface 201c is provided on the first chip body 201 at the end of the reaction channel 201g away from the liquid reservoir 201e. , the first negative pressure interface 201c has a through hole with a diameter of 1 mm, which penetrates the first chip body 201. The first chip body 201 is provided with a number of sampling vents 201a that correspond to and are connected to the liquid reservoir 201e. The liquid pool 201e is composed of a rectangle with a length of 4 mm and a width of 3 mm and two semicircles with a diameter of 3 mm in the width direction. The depth of the liquid pool 201e is 3 mm and the total volume is about 60 μL. The liquid pool 201e can be mixed with One end of the channel 201f is connected. The first chip body 201 is provided with an upper valve hole 201b that enables the liquid reservoir 201e to communicate with one end of the mixing channel 201f. The other end of the mixing channel 201f is connected to one end of the reaction channel 201g. The mixing channel 201f One end gradually wraps around from the outside to the inside and then wraps around in the opposite direction from the inside out to the other end of the mixing channel 201f. The radius gradually decreases as it wraps from the outside to the inside. Specifically, the first half of the mixing channel 201f is formed by The center is composed of semicircles with radii of 7 mm, 5 mm, 3 mm and 1 mm connected end to end. The radius gradually becomes larger when going out from the innermost end. The second half of the mixing channel 201f is composed of the mixing channel 201f. The center is composed of semicircles with radii of 1 mm, 3 mm, 5 mm and 7 mm connected end to end. The other end of the reaction channel 201g is connected to the waste liquid pool 201h. The width of the reaction channel 201g is 400 μm and the depth is 400 μm. The distance between two adjacent linear microchannels 201g-2 is 3 mm. The length of the linear microchannel 201g-2 is 10 mm. The connecting microchannel 201g-1 is a semicircle with a diameter of 3 mm. The waste liquid pool 201h is connected to the first The negative pressure interface 201c is connected, and a reaction layer 203 corresponding to the location of the reaction channel 201g is provided between the first chip body 201 and the second chip body 202. The reaction layer 203 is silica gel with a length of 10 mm, a width of 10 mm, and a thickness of 0.1 mm. plate, the waste liquid pool 201h is composed of a rectangle with a length of 20 mm, a width of 5 mm, and two semicircles with a diameter of 5 mm in the width direction. The depth of the waste liquid pool 201h is 4 mm, and the total volume is about 400 μL. The waste liquid The pool 201h is used to accommodate the waste liquid during the detection process to prevent the waste liquid from overflowing and contaminating the environment and instruments. Its volume can carry all the reagents in the liquid storage pool 201e.
进一步的,检测芯片还包括控制组件100,控制组件100包括机械阀103、连接在一起的第一支撑支架102和第二支撑支架101,芯片组件200支撑在第一支撑支架102和第二支撑支架101之间,第一支撑支架102的两端均开有第一连接孔102a,第二支撑架的两端均开有第二连接孔101a,使用连接销104经第一连接孔102a和第二连接孔101a将第一支撑支架102和第二支撑支架101连接在一起,第二芯片本体202上开有与上阀孔201b同轴心的下阀孔202a,第一支撑支架102和第二支撑支架101上分别开有第一导向孔102b和第二导向孔101b,机械阀103穿过第一导向孔102b并压入上阀孔201b后,机械阀103的下端能再依次穿过下阀孔202a和第二导向孔101b。Further, the detection chip also includes a control component 100. The control component 100 includes a mechanical valve 103, a first support bracket 102 and a second support bracket 101 connected together. The chip component 200 is supported on the first support bracket 102 and the second support bracket. 101, the first support bracket 102 has first connection holes 102a at both ends, and the second support bracket has second connection holes 101a at both ends. The connection pin 104 is used to pass through the first connection hole 102a and the second connection hole 101a. The connecting hole 101a connects the first support bracket 102 and the second support bracket 101 together. The second chip body 202 has a lower valve hole 202a coaxial with the upper valve hole 201b. The first support bracket 102 and the second support bracket 101a are connected together. The bracket 101 has a first guide hole 102b and a second guide hole 101b respectively. After the mechanical valve 103 passes through the first guide hole 102b and is pressed into the upper valve hole 201b, the lower end of the mechanical valve 103 can pass through the lower valve hole in turn. 202a and the second guide hole 101b.
进一步的,第一芯片本体201上还开有第二负压接口201d,第二负压接口201d和第一负压接口201c的结构相同,第二负压接口201d与混合通道201f的一端相接,机械阀103上设有若干在高度方向上间隔设置的出液通道103a,储液池201e能经对应的出液通道103a与混合通道201f的一端连通,当储液池201e经出液通道103a与混合通道201f刚好连通时,储液池201e覆盖出液通道103a的一端,混合通道201f的一端覆盖出液通道103a的另一端。Furthermore, the first chip body 201 is also provided with a second negative pressure interface 201d. The second negative pressure interface 201d has the same structure as the first negative pressure interface 201c. The second negative pressure interface 201d is connected to one end of the mixing channel 201f. , the mechanical valve 103 is provided with a plurality of liquid outlet channels 103a spaced apart in the height direction. The liquid reservoir 201e can be connected to one end of the mixing channel 201f through the corresponding liquid outlet channel 103a. When the liquid reservoir 201e passes through the liquid outlet channel 103a When it is just connected to the mixing channel 201f, the liquid reservoir 201e covers one end of the liquid outlet channel 103a, and one end of the mixing channel 201f covers the other end of the liquid outlet channel 103a.
进一步的,机械阀103上设有导向凸起103b,导向凸起103b与混合通道201f一端位置对齐时,最下面的出液通道103a的进液端能与多个储液池201e对应,最下面的出液通道103a具有至少两个进液端,当最下面的出液通道103a下端与第一芯片本体201下侧齐平时,至少有两个储液池201e分别覆盖不同的进液端;通过导向凸起103b和混合通道201f一端的位置设置,实现机械阀103与芯片组件200的安装周向定位,方便安装。Furthermore, the mechanical valve 103 is provided with a guide protrusion 103b. When the guide protrusion 103b is aligned with one end of the mixing channel 201f, the liquid inlet end of the bottom liquid outlet channel 103a can correspond to multiple liquid storage pools 201e. The liquid outlet channel 103a has at least two liquid inlets. When the lower end of the lowermost liquid outlet channel 103a is flush with the lower side of the first chip body 201, there are at least two liquid reservoirs 201e covering different liquid inlets respectively; by The position setting of the guide protrusion 103b and one end of the mixing channel 201f realizes the circumferential positioning of the mechanical valve 103 and the chip assembly 200, which facilitates installation.
使用检测芯片检测前,将导向凸起103b与混合通道201f一端的位置对齐,下压机械阀103使其压入上阀孔201b,当最下面的出液通道103a被按压至第一芯片本体201下侧所在位置时,装有检测样本和检测抗体的两个储液池201e分别与出液通道103a的两个进液端对应,停止下压机械阀103,将检测样本、检测抗体、洗涤液和化学发光底物分别注入不同的储液池201e内,在第一负压接口201c和第二负压接口201d处分别连接第一负压泵和第二负压泵。Before using the detection chip for detection, align the guide protrusion 103b with the position of one end of the mixing channel 201f, press down the mechanical valve 103 to press it into the upper valve hole 201b, when the bottom liquid outlet channel 103a is pressed to the first chip body 201 When the lower side is in the position, the two liquid storage pools 201e containing the detection sample and the detection antibody respectively correspond to the two liquid inlet ends of the liquid outlet channel 103a. Stop pressing the mechanical valve 103 to transfer the detection sample, detection antibody, and washing liquid. and the chemiluminescence substrate are respectively injected into different liquid reservoirs 201e, and the first negative pressure pump and the second negative pressure pump are respectively connected to the first negative pressure interface 201c and the second negative pressure interface 201d.
使用检测芯片混合检测样本和检测抗体时,第一负压泵先动作,将检测样本和检测抗体抽进混合通道201f内,当抽入的试剂靠近混合通道201f另一端时,第一负压泵停止动作,第二负压泵工作,将流向混合通道201f另一端的混合溶液朝着混合通道201f一端所在方向流动,完成一次循环混合;反复上述步骤,当循环混合次数达到设定的次数阈值时,本实施例中次数阈值优选为2次,第二负压泵停止动作,第一负压泵将混合好的溶液吸至反应通道201g内反应,参照图5和图6,可以看出经过不断循环混合后,溶液浓度一致,实现不同样本的均匀混合。When using the detection chip to mix the detection sample and detection antibody, the first negative pressure pump operates first to pump the detection sample and detection antibody into the mixing channel 201f. When the pumped reagent approaches the other end of the mixing channel 201f, the first negative pressure pump Stop the action, and the second negative pressure pump works to flow the mixed solution flowing to the other end of the mixing channel 201f in the direction of one end of the mixing channel 201f to complete one cycle of mixing; repeat the above steps, when the number of cycle mixing times reaches the set threshold , in this embodiment, the number threshold is preferably 2 times. The second negative pressure pump stops operating, and the first negative pressure pump sucks the mixed solution into the reaction channel 201g for reaction. Referring to Figures 5 and 6, it can be seen that after continuous After cyclic mixing, the solution concentration is consistent, achieving uniform mixing of different samples.
反应结束后,向下按压机械阀103,使中间的出液通道103a与注入有洗涤液的储液池201e对应,第一负压泵动作,将洗涤液依次经出液通道103a、混合通道201f和反应通道201g后冲进废液池201h,洗去反应层203上未参与反应的杂质及未结合的检测抗体;继续向下按压机械阀103,使最上面的出液通道103a与注入有化学发光底物的储液池201e对应,第一负压泵动作,将化学发光底物抽入反应通道201g内,与检测抗体上标记的酶反应,产生化学发光;反应通道201g上的直线微通道201g-2与反应层203上竖向包被的抗体条带构成发光点阵,测量得到各点的化学发光值。After the reaction is completed, the mechanical valve 103 is pressed downward to make the middle liquid outlet channel 103a correspond to the liquid storage tank 201e in which the washing liquid is injected. The first negative pressure pump operates and the washing liquid passes through the liquid outlet channel 103a and the mixing channel 201f in sequence. and the reaction channel 201g and then rush into the waste liquid pool 201h to wash away the impurities and unbound detection antibodies on the reaction layer 203 that did not participate in the reaction; continue to press the mechanical valve 103 downward to make the uppermost liquid outlet channel 103a and the injected chemical Corresponding to the liquid reservoir 201e of the luminescent substrate, the first negative pressure pump operates to pump the chemiluminescent substrate into the reaction channel 201g, where it reacts with the enzyme labeled on the detection antibody to produce chemiluminescence; the linear microchannel on the reaction channel 201g 201g-2 and the vertically coated antibody strips on the reaction layer 203 form a luminescent dot matrix, and the chemiluminescence value of each point is measured.
参照图7,(A)芯片的预处理包括再反应层203上包被捕获抗体、使用BSA封闭通道中空余点位和试剂装载;(B)抗原和检测抗体在混合通道201f中混合、反应;(C)反应通道201g中发生特异性免疫反应,捕获抗体与抗原特异性结合;(D)清洗未反应的试剂;(E)添加化学发光底物产生化学发光信号。Referring to Figure 7, (A) the preprocessing of the chip includes coating the capture antibody on the reactive layer 203, using BSA to seal the empty spots in the channel and loading reagents; (B) the antigen and detection antibody are mixed and reacted in the mixing channel 201f; (C) A specific immune reaction occurs in the reaction channel 201g, and the capture antibody specifically binds to the antigen; (D) Unreacted reagents are washed; (E) A chemiluminescent substrate is added to generate a chemiluminescent signal.
检测方法中借助检测芯片进行标志物的检测,实现同步加样,同步加样时,通过循环抽吸混合溶液的方式,使同步加样后的混合溶液混合均匀,提高检测精度;参照图4,使用多物理场模拟仿真软件对混合通道201f、反应通道201g的流体运动的流速进行了模拟,结果表明流体在通道中以10 mm/s的速度均匀运动,没有出现流体堵塞、流速突变、流体分布不均等情况,说明芯片中流体运动稳定。In the detection method, the detection chip is used to detect markers to achieve synchronous sample addition. During synchronous sample addition, the mixed solution after synchronous addition is mixed evenly by circulating the mixed solution to improve the detection accuracy; refer to Figure 4, Multi-physics simulation software was used to simulate the flow velocity of the fluid movement in the mixing channel 201f and the reaction channel 201g. The results showed that the fluid moved uniformly in the channel at a speed of 10 mm/s, and there was no fluid blockage, flow velocity mutation, or fluid distribution. The uneven situation indicates that the fluid movement in the chip is stable.
参照图6,混合通道201f内不断循环抽吸方式及混合通道201f特定结构的情况下,使用多物理场模拟仿真软件对本发明中流体的混合效果进行了模拟,结果表明,两种不同浓度的流体在经过混合通道201f后混合成了均一浓度的流体,说明双螺旋微通道1-4具有良好的混合效果。Referring to Figure 6, under the conditions of the continuous circulation pumping method in the mixing channel 201f and the specific structure of the mixing channel 201f, multi-physics simulation software was used to simulate the mixing effect of the fluid in the present invention. The results show that two fluids with different concentrations After passing through the mixing channel 201f, the fluid is mixed into a uniform concentration, indicating that the double helix microchannels 1-4 have a good mixing effect.
使用本发明节约了一次孵育、洗涤的操作,可以在17 min内完成多标志物的定量检测,提高检测效率;实现多个试剂的同步进样混合,通过芯片组件200和检测方法的结合,实现混合溶液的充分均匀混合,混合后的溶液在各个通道内流速均匀,实现多个浓度下的检测,检测更加可靠;适用于大多数标志物的检测,适用范围广。The use of the present invention saves the operation of one incubation and washing, can complete the quantitative detection of multiple markers within 17 minutes, and improves the detection efficiency; realizes the simultaneous injection and mixing of multiple reagents, and realizes through the combination of the chip component 200 and the detection method. The mixed solution is fully and evenly mixed, and the mixed solution has a uniform flow rate in each channel, enabling detection at multiple concentrations, and the detection is more reliable; it is suitable for the detection of most markers and has a wide range of applications.
实施例Example
为本发明的第四个实施例,本实施例与实施例1~实施例3的不同之处在于,对cTnI、CK-MB、Myo三种心肌标志物进行单独检测的方法,其包括以下步骤,This is the fourth embodiment of the present invention. The difference between this embodiment and Examples 1 to 3 lies in the method of separately detecting three myocardial markers: cTnI, CK-MB, and Myo, which includes the following steps ,
在反应层203上包被三条cTnI捕获抗体,对芯片进行组装与预处理之后,向第一储液池201e-1加入30 μL cTnI标准样品,向第二储液池201e-2加入30 μL cTnI与HRP偶联的检测抗体,向第三储液池201e-3中加入50 μL PBST洗涤液、向第四储液池201e-4中加入35μL Luminol-H2O2化学发光底物,各项试剂加载完成;Coat the reaction layer 203 with three cTnI capture antibodies. After assembling and preprocessing the chip, add 30 μL cTnI standard sample to the first reservoir 201e-1, and add 30 μL cTnI to the second reservoir 201e-2. For detection antibodies coupled to HRP, add 50 μL PBST washing solution to the third reservoir 201e-3, and add 35 μL Luminol-H 2 O 2 chemiluminescent substrate to the fourth reservoir 201e-4. Reagent loading is completed;
在第一负压接口201c和第二负压接口201d处用软管连接负压泵,用于驱动芯片内的流体;Connect the negative pressure pump with a hose at the first negative pressure interface 201c and the second negative pressure interface 201d for driving the fluid in the chip;
下压机械阀103,使最下面的出液通道103a与储液池201e的高度对应,第一负压泵动作,将第一储液池201e-1和第二储液池201e-2内的试剂抽至混合通道201f内,达到设定的时间后,第一负压泵停止动作,第二负压泵动作,将混合试剂从混合通道201f另一端往混合通道201f一端所在方向抽取,达到设定的时间后,第二负压泵停止动作,反复循环上述操作,直至循环次数达到设定的循环次数阈值时,第二负压泵彻底停止动作,得到混合均匀的样本;The mechanical valve 103 is pressed down so that the lowermost liquid outlet channel 103a corresponds to the height of the liquid reservoir 201e. The first negative pressure pump operates to move the liquid in the first liquid reservoir 201e-1 and the second liquid reservoir 201e-2. The reagent is pumped into the mixing channel 201f. After the set time is reached, the first negative pressure pump stops and the second negative pressure pump operates to pump the mixed reagent from the other end of the mixing channel 201f to the direction of one end of the mixing channel 201f. The set time is reached. After a certain period of time, the second negative pressure pump stops operating, and the above operation is repeatedly cycled until the number of cycles reaches the set cycle number threshold, and the second negative pressure pump completely stops operating to obtain a uniformly mixed sample;
第一负压泵动作,将混合均匀的样本抽至反应通道201g内,第一负压泵停止动作,静止孵育15分钟,使混合液在反应通道201g内发生特异性吸附,形成双抗体夹心结构;The first negative pressure pump operates to pump the evenly mixed sample into the reaction channel 201g. The first negative pressure pump stops operating and incubates statically for 15 minutes, allowing the mixture to specifically adsorb in the reaction channel 201g to form a double-antibody sandwich structure. ;
之后第一负压泵继续动作,将反应通道201g内的所有液体吸入废液池201h;Afterwards, the first negative pressure pump continues to operate, sucking all the liquid in the reaction channel 201g into the waste liquid pool 201h;
下压机械阀103使中间的出液通道103a与储液池201e的位置对应,第一负压泵动作,使第三储液池201e-3内的PBST洗涤液进入通道中,完成约15秒的连续洗涤,直至所有PBST洗涤缓冲液进入废液池201h,可以将未参与反应的杂质以及未结合的与HRP偶联的检测抗体冲进废液池201h;Press down the mechanical valve 103 to make the middle liquid outlet channel 103a correspond to the position of the liquid reservoir 201e. The first negative pressure pump operates to allow the PBST washing liquid in the third liquid reservoir 201e-3 to enter the channel. This takes about 15 seconds. Continuous washing until all the PBST washing buffer enters the waste liquid pool for 201h, impurities not participating in the reaction and unbound HRP-coupled detection antibodies can be flushed into the waste liquid pool for 201h;
继续下压机械阀103使最上面的出液通道103a与储液池201e的位置对应,第一负压泵动作,使Luminol-H2O2化学发光底物流入反应通道201g,与检测抗体上的HRP反应,随后流入废液池201h;Continue to press the mechanical valve 103 to make the top liquid outlet channel 103a correspond to the position of the liquid reservoir 201e. The first negative pressure pump operates to cause the Luminol-H 2 O 2 chemiluminescent substrate to flow into the reaction channel 201g and connect with the detection antibody. HRP reaction, and then flowed into the waste liquid pool for 201h;
反应过程结束后,将芯片放入化学发光检测仪中曝光20 s;After the reaction process is completed, put the chip into the chemiluminescence detector and expose it for 20 s;
其中,与最下面的出液通道103a连通的两个储液池201e分别命名为第一储液池201e-1和第二储液池201e-2,与中间的出液通道103a连通的储液池201e为第三储液池201e-3,与最上面的出液通道103a连通的储液池201e为第四储液池201e-4。Among them, the two liquid storage pools 201e connected to the lowermost liquid outlet channel 103a are respectively named the first liquid storage pool 201e-1 and the second liquid storage pool 201e-2, and the liquid storage pool 201e connected to the middle liquid outlet channel 103a The pool 201e is the third liquid storage pool 201e-3, and the liquid storage pool 201e connected to the uppermost liquid outlet channel 103a is the fourth liquid storage pool 201e-4.
CK-MB、Myo与cTnI的检测方法一致,仅需将标准样品、对应的捕获抗体、对应的与HRP偶联的检测抗体更换为与抗原对应的即可。The detection methods of CK-MB, Myo and cTnI are the same. You only need to replace the standard sample, the corresponding capture antibody, and the corresponding HRP-coupled detection antibody with those corresponding to the antigen.
cTnI、CK-MB、Myo三种心肌标志物的捕获抗体包被时浓度分别为25 μg/mL, 20 μg/mL, 40 μg/mL。cTnI、CK-MB、Myo三种心肌标志物与HRP偶联的检测抗体浓度分别为2.4 μg/mL,2 μg/mL,3 μg/mL。The concentrations of capture antibodies for cTnI, CK-MB, and Myo myocardial markers during coating were 25 μg/mL, 20 μg/mL, and 40 μg/mL respectively. The concentrations of detection antibodies conjugated to HRP for cTnI, CK-MB, and Myo myocardial markers are 2.4 μg/mL, 2 μg/mL, and 3 μg/mL respectively.
分别对5 pg/mL、10 pg/mL、20 pg/mL、80 pg/mL、320 pg/mL、640 pg/mL、1.28 ng/mL、2.56 ng/mL、5.12 ng/mL、10.24 ng/mL、20.48 ng/mL、40.96 ng/mL这一范围内的cTnI进行检测,结果如图9所示。对各点进行拟合,如图10所示,可得cTnI在20 pg/mL、80 pg/mL、320 pg/mL、640 pg/mL、1.28 ng/mL、2.56 ng/mL这一范围内呈良好的线性关系。5 pg/mL, 10 pg/mL, 20 pg/mL, 80 pg/mL, 320 pg/mL, 640 pg/mL, 1.28 ng/mL, 2.56 ng/mL, 5.12 ng/mL, 10.24 ng/ cTnI in the range of mL, 20.48 ng/mL, and 40.96 ng/mL was detected, and the results are shown in Figure 9. Fitting each point, as shown in Figure 10, shows that cTnI is within the range of 20 pg/mL, 80 pg/mL, 320 pg/mL, 640 pg/mL, 1.28 ng/mL, and 2.56 ng/mL. There is a good linear relationship.
分别对5 pg/mL、10 pg/mL、20 pg/mL、40 pg/mL、80 pg/mL、320 pg/mL、640 pg/mL、2.56 ng/mL、5.12 ng/mL、10.24 ng/mL、20.48 ng/mL、40.96 ng/mL这一范围内的CK-MB进行检测,结果如图9所示;对各点进行拟合,如图10所示,可得CK-MB在80 pg/mL、320 pg/mL、640 pg/mL、2.56 ng/mL、5.12 ng/mL、10.24 ng/mL这一范围内呈良好的线性关系。5 pg/mL, 10 pg/mL, 20 pg/mL, 40 pg/mL, 80 pg/mL, 320 pg/mL, 640 pg/mL, 2.56 ng/mL, 5.12 ng/mL, 10.24 ng/ CK-MB was detected in the range of mL, 20.48 ng/mL, and 40.96 ng/mL, and the results are shown in Figure 9; by fitting each point, as shown in Figure 10, it can be obtained that CK-MB is at 80 pg /mL, 320 pg/mL, 640 pg/mL, 2.56 ng/mL, 5.12 ng/mL, and 10.24 ng/mL, showing a good linear relationship.
分别对50 pg/mL、100 pg/mL、200 pg/mL、400 pg/mL、800 pg/mL、6.4 ng/mL、12.8ng/mL、51.2 ng/mL、102.4 ng/mL、204.8 ng/mL、409.6 ng/mL、819.2 ng/mL、这一范围内的Myo进行检测,结果如图9所示;对各点进行拟合,如图10所示,可得Myo在800 pg/mL、6.4ng/mL、12.8 ng/mL、51.2 ng/mL、102.4 ng/mL、204.8 ng/mL这一范围内呈良好的线性关系。50 pg/mL, 100 pg/mL, 200 pg/mL, 400 pg/mL, 800 pg/mL, 6.4 ng/mL, 12.8ng/mL, 51.2 ng/mL, 102.4 ng/mL, 204.8 ng/ mL, 409.6 ng/mL, 819.2 ng/mL, Myo was detected in this range, and the results are shown in Figure 9; fitting each point, as shown in Figure 10, it can be obtained that Myo is in the range of 800 pg/mL, There is a good linear relationship in the range of 6.4ng/mL, 12.8 ng/mL, 51.2 ng/mL, 102.4 ng/mL, and 204.8 ng/mL.
cTnI、CK-MB与Myo三种心肌标志物单独检测的发光点阵如图11所示。The luminescence lattice for the separate detection of three myocardial markers, cTnI, CK-MB and Myo, is shown in Figure 11.
实施例Example
为本发明的第五个实施例,与实施例1~4的不同之处在于,本实施例为对cTnI、CK-MB、Myo三种心肌标志物联合检测的方法,具体如下,This is the fifth embodiment of the present invention. The difference from Embodiments 1 to 4 is that this embodiment is a method for joint detection of three myocardial markers, cTnI, CK-MB, and Myo. The details are as follows:
在反应层203上包被cTnI、CK-MB、Myo的捕获抗体各一条,对芯片进行组装与预处理之后,向第一储液池201e-1加入30 μL标准样品,其中cTnI、CK-MB、Myo各10 μL;向第二储液池201e-2加入30 μL与HRP偶联的检测抗体,其中cTnI、CK-MB、Myo各自对应的与HRP偶联的检测抗体10 μL,初浓度分别为7.2 μg/mL、6 μg/mL、9 μg/mL;各向第三储液池201e-3中加入50 μL PBST洗涤液、向第四储液池201e-4中加入35 μL Luminol-H2O2化学发光底物;Coat the reaction layer 203 with one capture antibody each of cTnI, CK-MB, and Myo. After assembling and preprocessing the chip, add 30 μL of standard sample to the first reservoir 201e-1, including cTnI and CK-MB. , 10 μL each of Myo; add 30 μL of detection antibodies coupled to HRP into the second reservoir 201e-2, in which 10 μL of detection antibodies coupled to HRP corresponding to cTnI, CK-MB, and Myo were added, and the initial concentrations were respectively are 7.2 μg/mL, 6 μg/mL, and 9 μg/mL; add 50 μL PBST washing solution to the third reservoir 201e-3, and add 35 μL Luminol-H to the fourth reservoir 201e-4. 2 O 2 chemiluminescence substrate;
在第一负压接口201c和第二负压接口201d处用软管连接负压泵,用于驱动芯片内的流体;Connect the negative pressure pump with a hose at the first negative pressure interface 201c and the second negative pressure interface 201d for driving the fluid in the chip;
下压机械阀103,使最下面的出液通道103a与储液池201e的高度对应,第一负压泵动作,将第一储液池201e-1和第二储液池201e-2内的试剂抽至混合通道201f内,达到设定的时间后,第一负压泵停止动作,第二负压泵动作,将混合试剂从混合通道201f另一端往混合通道201f一端所在方向抽取,达到设定的时间后,第二负压泵停止动作,反复循环上述操作,直至循环次数达到设定的循环次数阈值时,第二负压泵彻底停止动作,得到混合均匀的样本;The mechanical valve 103 is pressed down so that the lowermost liquid outlet channel 103a corresponds to the height of the liquid reservoir 201e. The first negative pressure pump operates to move the liquid in the first liquid reservoir 201e-1 and the second liquid reservoir 201e-2. The reagent is pumped into the mixing channel 201f. After the set time is reached, the first negative pressure pump stops and the second negative pressure pump operates to pump the mixed reagent from the other end of the mixing channel 201f to the direction of one end of the mixing channel 201f. The set time is reached. After a certain period of time, the second negative pressure pump stops operating, and the above operation is repeatedly cycled until the number of cycles reaches the set cycle number threshold, and the second negative pressure pump completely stops operating to obtain a uniformly mixed sample;
第一负压泵动作,将混合均匀的样本抽至反应通道201g内,第一负压泵停止动作,静止孵育15分钟,使混合液在反应通道201g内发生特异性吸附,形成双抗体夹心结构;The first negative pressure pump operates to pump the evenly mixed sample into the reaction channel 201g. The first negative pressure pump stops operating and incubates statically for 15 minutes, allowing the mixture to specifically adsorb in the reaction channel 201g to form a double-antibody sandwich structure. ;
之后第一负压泵继续动作,将反应通道201g内的所有液体吸入废液池201h;Afterwards, the first negative pressure pump continues to operate, sucking all the liquid in the reaction channel 201g into the waste liquid pool 201h;
下压机械阀103使中间的出液通道103a与储液池201e的位置对应,第一负压泵动作,使第三储液池201e-3内的PBST洗涤液进入通道中,完成约15秒的连续洗涤,直至所有PBST洗涤缓冲液进入废液池201h,可以将未参与反应的杂质以及未结合的与HRP偶联的检测抗体冲进废液池201h;Press down the mechanical valve 103 to make the middle liquid outlet channel 103a correspond to the position of the liquid reservoir 201e. The first negative pressure pump operates to allow the PBST washing liquid in the third liquid reservoir 201e-3 to enter the channel. This takes about 15 seconds. Continuous washing until all the PBST washing buffer enters the waste liquid pool for 201h, impurities not participating in the reaction and unbound HRP-coupled detection antibodies can be flushed into the waste liquid pool for 201h;
继续下压机械阀103使最上面的出液通道103a与储液池201e的位置对应,第一负压泵动作,使Luminol-H2O2化学发光底物流入反应通道201g,与检测抗体上的HRP反应,随后流入废液池201h;Continue to press the mechanical valve 103 to make the top liquid outlet channel 103a correspond to the position of the liquid reservoir 201e. The first negative pressure pump operates to cause the Luminol-H 2 O 2 chemiluminescent substrate to flow into the reaction channel 201g and connect with the detection antibody. HRP reaction, and then flowed into the waste liquid pool for 201h;
反应过程结束后,将芯片放入化学发光检测仪中曝光20 s;After the reaction process is completed, put the chip into the chemiluminescence detector and expose it for 20 s;
反应通道201g的三条横向直线微通道201g-2与反应层203上的三条竖向捕获抗体带交叉,cTnI、CK-MB、Myo每种标志物各有三个检测点,共生成九个检测点,对图像进行处理,得到各点的化学发光值,将它们的平均灰度值减去背景值即可用于样品浓度的计算。The three horizontal linear microchannels 201g-2 of the reaction channel 201g intersect with the three vertical capture antibody bands on the reaction layer 203. Each marker of cTnI, CK-MB, and Myo has three detection points, generating a total of nine detection points. The image is processed to obtain the chemiluminescence value of each point, and their average gray value minus the background value can be used to calculate the sample concentration.
cTnI、CK-MB与Myo三种心肌标志物联合检测的发光点阵如图12所示。The luminescent lattice for joint detection of three myocardial markers, cTnI, CK-MB and Myo, is shown in Figure 12.
不难发现,在不脱离本发明的精神和范围的条件下,对本发明进行简单改变,例如改变芯片结构,改变反应层材料,改变检测的标志物,改变试剂种类及用量均可以达成预期目的,对本发明进行轻易更改和变动都处于本发明的保护范围之内。It is not difficult to find that, without departing from the spirit and scope of the present invention, simple changes to the present invention, such as changing the chip structure, changing the reaction layer material, changing the detection markers, changing the type and dosage of the reagents, can achieve the expected purpose. Easy modifications and changes to the present invention are within the protection scope of the present invention.
重要的是,应注意,在多个不同示例性实施方案中示出的本申请的构造和布置仅是例示性的。尽管在此公开内容中仅详细描述了几个实施方案,但参阅此公开内容的人员应容易理解,在实质上不偏离该申请中所描述的主题的新颖教导和优点的前提下,许多改型是可能的(例如,各种元件的尺寸、尺度、结构、形状和比例、以及参数值(例如,温度、压力等)、安装布置、材料的使用、颜色、定向的变化等)。例如,示出为整体成形的元件可以由多个部分或元件构成,元件的位置可被倒置或以其它方式改变,并且分立元件的性质或数目或位置可被更改或改变。因此,所有这样的改型旨在被包含在本发明的范围内。可以根据替代的实施方案改变或重新排序任何过程或方法步骤的次序或顺序。在权利要求中,任何“装置加功能”的条款都旨在覆盖在本文中所描述的执行所述功能的结构,且不仅是结构等同而且还是等同结构。在不背离本发明的范围的前提下,可以在示例性实施方案的设计、运行状况和布置中做出其他替换、改型、改变和省略。因此,本发明不限制于特定的实施方案,而是扩展至仍落在所附的权利要求书的范围内的多种改型。It is important to note that the construction and arrangements of the present application shown in various exemplary embodiments are illustrative only. Although only a few embodiments are described in detail in this disclosure, those reviewing this disclosure will readily appreciate that many modifications are possible without materially departing from the novel teachings and advantages of the subject matter described in this application. is possible (e.g. changes in size, scale, structure, shape and proportion of various elements, as well as parameter values (e.g. temperature, pressure, etc.), mounting arrangements, use of materials, colors, orientations, etc.). For example, an element shown as integrally formed may be constructed from multiple parts or elements, the position of elements may be inverted or otherwise altered, and the nature or number or position of discrete elements may be altered or varied. Accordingly, all such modifications are intended to be included within the scope of this invention. The order or sequence of any process or method steps may be changed or reordered according to alternative embodiments. In the claims, any "means-plus-function" clause is intended to cover the structures described herein as performing the recited function and not only structural equivalents but also equivalent structures. Other substitutions, modifications, changes and omissions may be made in the design, operation and arrangement of the exemplary embodiments without departing from the scope of the invention. Therefore, the invention is not limited to particular embodiments, but extends to various modifications which still fall within the scope of the appended claims.
此外,为了提供示例性实施方案的简练描述,可以不描述实际实施方案的所有特征(即,与当前考虑的执行本发明的最佳模式不相关的那些特征,或与实现本发明不相关的那些特征)。Furthermore, in order to provide a concise description of the exemplary embodiments, not all features of an actual implementation may be described (i.e., those features that are not relevant to the best mode presently contemplated for carrying out the invention, or that are not relevant to carrying out the invention) feature).
应理解的是,在任何实际实施方式的开发过程中,如在任何工程或设计项目中,可做出大量的具体实施方式决定。这样的开发努力可能是复杂的且耗时的,但对于那些得益于此公开内容的普通技术人员来说,不需要过多实验,所述开发努力将是一个设计、制造和生产的常规工作。It is understood that numerous implementation-specific decisions may be made during the development of any actual implementation, as in any engineering or design project. Such a development effort might be complex and time consuming, but would be a routine undertaking of design, manufacture and production without undue experimentation to those of ordinary skill having the benefit of this disclosure .
应说明的是,以上实施例仅用以说明本发明的技术方案而非限制,尽管参照较佳实施例对本发明进行了详细说明,本领域的普通技术人员应当理解,可以对本发明的技术方案进行修改或者等同替换,而不脱离本发明技术方案的精神和范围,其均应涵盖在本发明的权利要求范围当中。It should be noted that the above embodiments are only used to illustrate the technical solution of the present invention rather than to limit it. Although the present invention has been described in detail with reference to the preferred embodiments, those of ordinary skill in the art should understand that the technical solution of the present invention can be carried out. Modifications or equivalent substitutions without departing from the spirit and scope of the technical solution of the present invention shall be included in the scope of the claims of the present invention.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110818188.0A CN113567421B (en) | 2021-07-20 | 2021-07-20 | Quantitative detection method for multiple markers |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110818188.0A CN113567421B (en) | 2021-07-20 | 2021-07-20 | Quantitative detection method for multiple markers |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113567421A CN113567421A (en) | 2021-10-29 |
CN113567421B true CN113567421B (en) | 2023-11-17 |
Family
ID=78165642
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110818188.0A Active CN113567421B (en) | 2021-07-20 | 2021-07-20 | Quantitative detection method for multiple markers |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113567421B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114471757B (en) * | 2022-01-24 | 2023-05-12 | 扬州大学 | Multistage magnetic control triple detection micro-fluidic chip and detection method thereof |
CN114669338B (en) * | 2022-04-15 | 2023-05-12 | 扬州大学 | Microfluidic chip based on urine detection disease |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008147382A1 (en) * | 2006-09-27 | 2008-12-04 | Micronics, Inc. | Integrated microfluidic assay devices and methods |
WO2019007036A1 (en) * | 2017-07-05 | 2019-01-10 | 京东方科技集团股份有限公司 | Micro-fluidic chip, device and method for chemiluminescent immunoassay |
CN109416331A (en) * | 2017-01-05 | 2019-03-01 | 伊鲁米那股份有限公司 | Reagent hybrid system and method |
CN109870582A (en) * | 2019-02-27 | 2019-06-11 | 华中科技大学 | A multi-target magnetic immunochemiluminescence microfluidic chip detection platform and method |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8444920B2 (en) * | 2009-09-16 | 2013-05-21 | Weiqun Liu | O-ring systems and methods for quantification of multiplex biomarkers in multiple samples |
GB201704758D0 (en) * | 2017-01-05 | 2017-05-10 | Illumina Inc | Reagent channel mixing systema and method |
-
2021
- 2021-07-20 CN CN202110818188.0A patent/CN113567421B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008147382A1 (en) * | 2006-09-27 | 2008-12-04 | Micronics, Inc. | Integrated microfluidic assay devices and methods |
CN109416331A (en) * | 2017-01-05 | 2019-03-01 | 伊鲁米那股份有限公司 | Reagent hybrid system and method |
WO2019007036A1 (en) * | 2017-07-05 | 2019-01-10 | 京东方科技集团股份有限公司 | Micro-fluidic chip, device and method for chemiluminescent immunoassay |
CN109870582A (en) * | 2019-02-27 | 2019-06-11 | 华中科技大学 | A multi-target magnetic immunochemiluminescence microfluidic chip detection platform and method |
Also Published As
Publication number | Publication date |
---|---|
CN113567421A (en) | 2021-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109647553B (en) | Microfluidic device for joint detection of multi-index diseases | |
Huang et al. | Active droplet-array microfluidics-based chemiluminescence immunoassay for point-of-care detection of procalcitonin | |
US10126294B2 (en) | Sample metering device and assay device with integrated sample dilution | |
Hervás et al. | Electrochemical immunosensing on board microfluidic chip platforms | |
JP5977674B2 (en) | Fluid mixing and transport in microfluidic systems | |
AU676547B2 (en) | Capsule chemistry sample liquid analysis system and method | |
US9671398B2 (en) | Apparatus and method for identifying a hook effect and expanding the dynamic range in point of care immunoassays | |
US8137905B2 (en) | Apparatus and method for determining an analyte in a fluid | |
CN113567421B (en) | Quantitative detection method for multiple markers | |
US9061283B2 (en) | Sample metering device and assay device with integrated sample dilution | |
US20150093771A1 (en) | Microfluidic analytical device for analysis of chemical or biological samples, method and system thereof | |
US8557199B2 (en) | Self-powered microfluidic devices, methods and systems | |
CA2694541A1 (en) | Microfluidic devices, methods and systems for detecting target molecules | |
CN101561444A (en) | Micro-fluidic chip with an integrated PDMS surface tension minipump and application thereof | |
He et al. | Composable microfluidic plates (cPlate): A simple and scalable fluid manipulation system for multiplexed enzyme-linked immunosorbent assay (ELISA) | |
EP3788372B1 (en) | Immunoassay for an automated system | |
CN111013677B (en) | Microfluidic chip, detection device and detection method | |
CN115011454B (en) | Nucleic acid detection device and method | |
CN110935497A (en) | Integrated microfluidic immunodetection chip and application thereof | |
CN114814261B (en) | Automatic chemiluminescent immunoassay chip and detection method thereof | |
Chang et al. | Low cost 3D microfluidic chips for multiplex protein detection based on photonic crystal beads | |
Wiktor et al. | Microreactor array device | |
Min et al. | An automated microfluidic chemiluminescence immunoassay platform for quantitative detection of biomarkers | |
Sista | Development of a digital microfluidic lab-on-a-chip for automated immunoassay with magnetically responsive beads | |
KR102244375B1 (en) | Apparatus for detecting analyte by simultaneous movement of particles and solution and detection method using the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |